<?xml version='1.0' encoding='UTF-8'?>
<PolymerNanocomposite><PDB_ID>4AU8</PDB_ID><DATA_SOURCE><Citation><CitationType>research article</CitationType><Publication>Bioorganic &amp; Medicinal Chemistry Letters</Publication><Title>Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors</Title><Author>Malmström, Jonas</Author><Author>Viklund, Jenny</Author><Author>Slivo, Can</Author><Author>Costa, Ana</Author><Author>Maudet, Mickaël</Author><Author>Sandelin, Catrin</Author><Author>Hiller, Gösta</Author><Author>Olsson, Lise-Lotte</Author><Author>Aagaard, Anna</Author><Author>Geschwindner, Stefan</Author><Author>Xue, Yafeng</Author><Author>Vasänge, Mervi</Author><Publisher>Elsevier</Publisher><PublicationYear>2012</PublicationYear><DOI>10.1016/j.bmcl.2012.07.068</DOI><Volume>22</Volume><Issue>18</Issue></Citation></DATA_SOURCE><MATERIALS><Matrix><MatrixComponent><ChemicalName>Cyclin-dependent-like kinase 5</ChemicalName><MacroMoleculeClass>TRANSFERASE</MacroMoleculeClass><MacroMoleculeType>Protein</MacroMoleculeType><ManufacturerOrSourceName>Homo sapiens</ManufacturerOrSourceName><MolecularWeight><value>68483.68</value></MolecularWeight></MatrixComponent></Matrix></MATERIALS><CHARACTERIZATION><XRay_Diffraction_and_Scattering><Equipment>ESRF BEAMLINE ID14-4 ADSC CCD</Equipment><Description>Data collection temperature: 100 K, Resolution: 1.9</Description></XRay_Diffraction_and_Scattering></CHARACTERIZATION><PROPERTIES><Biological><Sequence>GAMGSQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP</Sequence><SpaceGroup>P 41 21 2</SpaceGroup><pH>5.4</pH></Biological></PROPERTIES></PolymerNanocomposite>